Zymeworks
ZYME
103 hedge funds and large institutions have $1.08B invested in Zymeworks in 2019 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 9 closing their positions.
333% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 9
122% more capital invested
Capital invested by funds: $487M → $1.08B (+$595M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
39% more funds holding
Funds holding: 74 → 103 (+29)
10.14% more ownership
Funds ownership: 50.26% → 60.4% (+10%)
0% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 25
44% less call options, than puts
Call options by funds: $4.13M | Put options by funds: $7.44M
Top Buyers
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$58.7M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$32.2M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$25.4M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$14.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$12M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FHA
101
Flagship Harbor Advisors
Boston,
Massachusetts
| $4K | – | – | – |
|
|
WEC
102
Winslow Evans & Crocker
Boston,
Massachusetts
| $4K | – | – | – |
|
|
HR
103
Howe & Rusling
Rochester,
New York
| $1K | -$908 | -25 | -50% |
|
|
CCM
104
Camber Capital Management
Boston,
Massachusetts
| – | -$37.2M | -1,500,000 | Closed |
|
|
PVI
105
Pura Vida Investments
New York
| – | -$1.24M | -50,000 | Closed |
|
|
GIP
106
Granite Investment Partners
El Segundo,
California
| – | -$201K | -8,091 | Closed |
|
107
Group One Trading
Chicago,
Illinois
| – | -$152K | -4,189 | Closed |
|
|
CG
108
Cutler Group
San Francisco,
California
| – | -$83.6K | -2,300 | Closed |
|
|
TC
109
Truvestments Capital
Sarasota,
Florida
| – | -$25K | -1,000 | Closed |
|
|
QT
110
Quantbot Technologies
New York
| – | -$19K | -800 | Closed |
|
|
TRCT
111
Tower Research Capital (TRC)
New York
| – | -$15K | -586 | Closed |
|
112
KBC Group
Brussels,
Belgium
| – | -$2K | -85 | Closed |
|
ZYME Hedge Fund Activity: Q4 2019 in Review
103 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2019, worth a combined $1.08B — up 122% from $487M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new ZYME positions and 9 closed out — a net gain of 30 holders — while 25 added to existing stakes and 25 trimmed.
The largest buyer was Fidelity International, opening a new position worth an estimated $58.7M. The largest seller was Camber Capital Management, exiting entirely with an estimated $37.2M sold.
- 103 institutional investors held Zymeworks (ZYME) as of Q4 2019, up from 74 in Q3 2019.
- Funds reported $1.08B of Zymeworks stock for Q4 2019, up 122% quarter-over-quarter.
- 39 funds opened new Zymeworks positions in Q4 2019 and 9 closed out, a net change of +30 holders.
- The largest Zymeworks buyer in Q4 2019 was Fidelity International, an estimated $58.7M added.
- The largest Zymeworks seller in Q4 2019 was Camber Capital Management, an estimated $37.2M sold.
Based on aggregated 13F filings for Q4 2019.